ArticleFrontiers in immunology2026
HLA genotyping and clinical characteristics of early-onset and late-onset anti-LGI1 encephalitis: a single-center cohort study in China.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the human leukocyte antigen (HLA) associations and clinical characteristics of anti-Leucine-rich glioma-inactivated 1 (LGI1) encephalitis in a Chinese cohort, focusing on potential differences between early-onset and late-onset patients. Methods: Eighty patients diagnosed with anti-LGI1 encephalitis at Peking Union Medical College Hospital between the years 2016 and 2024 were included. Patients were stratified into early-onset (<50 years, n=22) and late-onset (≥50 years, n=58) groups for clinical features analysis. High-resolution NGS HLA genotyping was performed and compared with 984 healthy controls. Logistic and linear regressions were used to analyze disease susceptibility, age of onset associations, and prognostic factors. Results: Compared with the late-onset group, the early-onset group more frequently presented with generalized tonic-clonic seizures (GTCS) as the initial symptom (45.5% Conclusions: This study suggests that early-onset and late-onset anti-LGI1 encephalitis may possess differential immunogenetic and clinical profiles. In addition to the broad susceptibility conferred by DRB1*07:01, the presence of A*02:01 is significantly associated with an earlier onset age. These findings provide insights into the role of HLA genotyping in accounting for the observed differences between early-onset and late-onset patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.